Table 3.
Models | PA levels | Recommended f/v intake | ||
---|---|---|---|---|
OR (95%) | p-value | OR (95%) | p-value | |
Model 1a: Adjusted for baseline levels only as fixed effects | 0.98 (0.58–1.67) | .95 | 1.45 (1.07–1.97) | .02* |
Model 2b: Adjusted for baseline levels as fixed effects and church (random effect/ intercept) | 0.97 (0.56–1.69) | .91 | 1.59 (0.74–3.42) | .23 |
Model 3c: Adjusted for baseline levels and participants characteristics (fixed effects) and for church (random effect/intercept) | 0.81 (0.42–1.59) | .55 | 1.49 (0.65–3.39) | .35 |
CI confidence interval; OR odds ratio; PA physical activity.
*Statistically significant difference; significance level was set at α = 0.05.
aModel 1 represents the primary outcome analysis, providing the adjusted OR for treatment effect accounting for participants baseline levels (n’s = 858; 814).
bModel 2 represents the primary outcome analysis, providing the adjusted OR for treatment effect accounting for baseline levels and participants’ clustering in churches (n’s = 851; 807).
cModel 3 provides the adjusted OR for treatment effect accounting for participants’ baseline levels, clustering in churches, and additional participant characteristics selected post hoc (n’s = 793; 766).